Treatment of stage IIIB non-small-cell lung cancer with surgery followed by infusion of tumor infiltrating lymphocytes and recombinant interleukin-2: A pilot study

Journal of Immunotherapy

Volumn 19, Issue 3, 1996, Pages 224-230

  Melioli, Giovanni ^a   Ratto, Giovanni Battista ^a   Ponte, Marco ^a   Guastella, Marina ^a   Semino, Claudia ^a   Fantino, Giovanni ^a   Tassara, Elisabetta ^a   Pasquetti, Wanda ^a   Mereu, Carlo ^b   Merlo, Franco ^a   Reggiardo, Giorgio ^a   Morasso, Gabriella ^b   Santi, Leonardo ^c   Moretta, Lorenzo ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

Author keywords

In vivo infusion; Non small cell lung cancer; Recombinant interleukin 2; Surgery; Tumor infiltrating lymphocytes

Indexed keywords

INDOMETACIN; PARACETAMOL; RECOMBINANT INTERLEUKIN 2;

ADOPTIVE IMMUNOTHERAPY; ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; FEVER; HUMAN; HYPOTENSION; LUNG NON SMALL CELL CANCER; MALE; PRIORITY JOURNAL; PROGNOSIS; SUBCUTANEOUS DRUG ADMINISTRATION; TUMOR ASSOCIATED LEUKOCYTE;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERLEUKIN-2; LUNG NEOPLASMS; LYMPHOCYTES, TUMOR-INFILTRATING; MALE; MIDDLE AGED; NEOPLASM STAGING; RECOMBINANT PROTEINS;

EID: 8944253774     PISSN: 15249557     EISSN: 15374513     Source Type: Journal    
DOI: 10.1097/00002371-199605000-00007     Document Type: Article

References (17)

1. Ratto GB, Piacenza G, Frola C, et al. Chest wall involvement by lung cancer: computed tomographic detection and results of operation. Ann Thorac Surg 1991;51:182-8.
2. Mountain CF. A new international staging system for lung cancer. Chest 1986;89:225S-33S.
3. Sause WT, Scott C, Tailor S, et al. Radiation Therapy Oncology Group (RTOG) 88-08 and Eastern Cooperative Oncology Group (ECOG) 4588: preliminary results of a phase III trial in regional advanced unresectable non small cell lung cancer. J Natl Cancer Inst 1995;87:198-205.
4. Dillman RO, Seagren SL, Propert KJ, et al. A randomized trial of induction chemotherapy plus high dose radiation versus radiation alone in stage III non small cell lung cancer. N Engl J Med 1990;330:940-5.
5. Holmes EC. Adjuvant treatment in resected lung cancer. Semin Surg Oncol 1990;6:263-7.
6. Rosenberg SA, Packard BS, Aebersold PM, et al. Use of tumor infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma: a preliminary report. N Engl J Med 1988,319:1676-80.
7. Kradin RL, Kurnick JT, Lazarus DS, et al. Tumor infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet 1989;1:577-80.
8. Dillman RO, Oldham RK, Barth NM, et al. Continuous interleukin-2 and tumor infiltrating lymphocytes as treatment of advanced melanoma: a National Biotherapy Study Group trial. Cancer 1991;68:1-8.
9. Aoki Y, Takakuwa K, Kodama S, et al. Use of adoptive transfer of tumor-infiltrating lymphocytes alone or in combination with cisplatin-containing chemotherapy in patients with epithelial ovarian cancer. Cancer Res 1991;51:1934-9.
10. Ravaud A, Legrand E, Delaunay MM, et al. A phase I trial of repeated tumor infiltrating lymphocytes (TIL) infusion in metastatic melanoma. Br J Cancer 1995;71:331-6.
11. Goedegebuure PF, Douville LM, Li O, et al. Adoptive immunotherapy with tumor infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma: a pilot study. J Clin Oncol 1995; 1: 1939-49.
12. Melioli G, Ratto GB, Guastella M, et al. Isolation and in vitro expansion of lymphocytes infiltrating non-small cell lung carcinoma: functional and molecular characterization for their use in adoptive immunotherapy. Eur J Cancer 1994; 30:97-102.
13. Yoshino I, Yano Y, Yoshikai Y, et al. Oligoclonal T lymphocytes infiltrating human lung cancer tissues. Int J Cancer 1991;47:654-8.
14. + human “natural killer” cells. Int J Cancer 1989;44:124-32.
15. Melioli G, Guastella M, Semino C, et al. Proliferative, phenotypic and functional characteristics of tumor infiltrating lymphocytes, obtained from unselected patients with malignant melanomas and expanded in vitro in the presence of rIL-2. Melanoma Res 1994;4:127-33.
16. BMDP statistical software. University of California Press, Berkeley: 1992.
17. Griffith KD, Read EJ, Carasquillo JA. In vivo distribution of adoptively transferred indium-lll-labeled tumor infiltrating lymphocytes and peripheral blood cells in patients with metastatic melanoma. J Natl Cancer Inst 1989;81:1709-17.